Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJohn J. Harding
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1016/s0161-6420(01)00626-1
10.1016/s0161-6420(01)00626-1
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists
10.1212/wnl.54.11.2066 · 2000
10.1136/bmj.296.6618.320
10.1136/bmj.296.6618.320
X-ray analysis of βB2-crystallin and evolution of the oligomeric lens proteins
10.1038/347776a0 · 1990
Conformational changes induced in lens α- and γ- crystallins by modification with glucose 6-phosphate. Implications for cataract
10.1042/bj2460761 · 1987
Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen
10.1016/0014-4835(92)90129-g · 1992
Tau in Alzheimer neurofibrillary tangles
10.1042/bj2730127 · 1991
Conformational disease
10.1016/s0140-6736(97)02073-4 · 1997
Glucose and ageing
10.1038/scientificamerican0587-90 · 1987
Low-dose aspirin and risk of cataract and subtypes in a randomised trial of US physicians
10.1076/opep.5.3.133.8368 · 1998
Phase separation in lens cytoplasm is genetically linked to cataract formation in the Philly mouse
10.1073/pnas.84.1.122 · 1987
α-Crystallin as a molecular chaperone
10.1016/s1350-9462(98)00030-5 · 1999
Aspirin in the prevention of strokes
10.1016/s0753-3322(00)88501-7 · 1999
Interaction of α-crystallin with spin-labelled peptides
10.1021/bi00002a015 · 1995
Aging, Metabolism and Alzheimer disease: review and hypotheses
10.1006/exnr.1996.6339 · 1997
Molecular chaperones protect against glycation-induced inactivation of glucose 6-phosphate dehydrogenase
10.1111/j.1432-1033.1995.tb20684.x · 1995
Inhibition of 6-phosphogluconate dehydrogenase by carbamylation and protection by α-crystallin, a chaperone-like protein
10.1006/bbrc.1996.0794 · 1996
The small heat-shock protein, αB-crystallin, has a variable quaternary structure
10.1006/jmbi.1997.1611 · 1998
Conformational changes in human lens proteins in cataract
10.1042/bj1290097 · 1972
Nonenzymatic posttranslational modification of proteins in vivo
10.1016/s0065-3233(08)60066-2 · 1985
Unresolved referenced work
Kept as external metadata until matched
Pathophysiology of cataract
10.1097/00055735-199302000-00004 · 1993
Estrogens and cataract
10.1001/archopht.1994.01090240017008 · 1994
Can drugs or micronutrients prevent cataract?
10.2165/00002512-200118070-00001 · 2001
Protection against cataract by aspirin, paracetamol and ibuprofen
10.1111/j.1755-3768.1989.tb04102.x · 1989
Glycation-induced inactivation of malate dehydrogenase: protection by aspirin and a lens molecular chaperone, alpha-crystallin
10.1016/0925-4439(95)00120-4 · 1996
Alpha-crystallin acting as a molecular chaperone protects catalase against steroid-induced inactivation
10.1016/0014-5793(96)00134-2 · 1996
Protection of enzymes by α-crystallin acting as a molecular chaperone
10.1016/s0141-8130(98)00027-0 · 1998
Abnormal haem binding and globin SH group blockade in unstable haemoglobins
10.1038/2181214a0 · 1968
Chemoprevention of colorectal cancer
10.1056/nejm200006293422606 · 2000
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore longitudinal study of aging
10.1212/wnl.48.6.1517 · 1997
Is there evidence of an estrogen effect on age-related lens opacities?
10.1001/archopht.1994.01090130095025 · 1994
Drug use and five-year incidence of age-related cataracts
10.1016/s0161-6420(01)00656-x · 2001
A review of cancer chemopreventive agents
10.2174/0929867013372229 · 2001
The molecular chaperone α-crystallin is in kinetic competition with aggregation to stabilise a monomeric molten-globule form of α-lactalbumin
10.1042/0264-6021:3540079 · 2001
3.8 Million blinded by cataract each year: projections from the first epidemiological study of incidence of cataract blindness in India
10.1136/bjo.74.6.341 · 1990
India-US case-control study of age-related cataracts
10.1001/archopht.1989.01070010688028 · 1989
Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study
2000
Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer
10.1093/qjmed/94.8.445 · 2001
Non-enzymic modification of lens proteins by glucose and fructose: effects of ibuprofen
10.1016/0014-4835(91)90260-l · 1991
Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak
10.1093/carcin/22.9.1393 · doi-reference
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress
10.1073/pnas.91.16.7787 · doi-reference
X-ray analysis of the eye lens protein γII-crystallin at 1.9 A resolution
10.1016/s0022-2836(83)80232-0 · doi-reference
Lack of evidence for aspirin use and prevention of cataracts
10.1001/archopht.1987.01060090087034 · doi-reference
Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer’s disease
10.1038/nm0896-871 · doi-reference
Advanced glycation endproducts contribute to amyloidosis in Alzheimer disease
10.1073/pnas.91.11.4766 · doi-reference
A missense mutation in the αB-crystallin gene causes a desmin-related myopathy
10.1038/1765 · doi-reference
10.1016/s0140-6736(86)91834-9
10.1016/s0140-6736(86)91834-9 · doi-reference
Diabetic cataract formation: potential role of glycosylation of lens crystallins
10.1073/pnas.75.6.2918 · doi-reference
Hormone replacement: therapeutic strategies in the treatment of Alzheimer’s disease and ageing-related cognitive disorders
10.1517/13543776.7.6.611 · doi-reference
Deamidation of glutaminyl and asparaginyl residues in peptides and proteins
10.1016/b978-0-12-152808-9.50013-4 · doi-reference
Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction
10.1054/mehy.1999.0023 · doi-reference